The effect of circHIPK3 on gemcitabine resistance is attributed to its negative regulatory role on miR-330-5p which enables RASSF1 activity, favoring proliferation, invasiveness, migration, EMT, and apoptosis inhibition in pancreatic cancer (64). The gene discussed is RASSF1; the disease is familial pancreatic carcinoma.